(A) Larval nuclear extracts derived from the HA-6His-tagged ISWI line [6] were affinity purified on a His-Trap column [14] and 3% of the total input extract (I), supernatant (U), and 30% of the eluted fractions were subjected to Western blot analysis with aPAR (lanes 1–3) and aISWI (lanes 4–6) antibodies. The band pointed by the double arrow is lost in a mock purification.
(B) Upper panel: aPAR Western blot of purifed histones (lanes 1 and 2), recombinant p53 (lanes 3 and 4), ISWI (lanes 5 and 6), and NFκB p50 subunit (lanes 7 and 8) after incubation in presence (lanes 2, 4, 6, and 8) or absence (lanes 1, 3, 5, and 7) of purified PARP. PARP was also incubated in the absence of any other potential substrate (lane 9). Lower panel: The same filter was stained with AuroDye (GE Healthcare) to reveal the blotted PARylated and non-PARylated proteins. The expected migrations of unmodified p50, p53, and ISWI are indicated by arrows.
(C) Upper panel: aPAR Western blot of 2 nmol each of full length ISWI (lanes 1 and 2), N-terminal truncated portion of ISWI (lanes 3 and 4; ISWI-N), C-terminal truncated portion of ISWI (lanes 5 and 6; ISWI-C) after incubation (15 min) in presence (lanes 2, 4, 6) or absence (lanes 1, 3, 5) of purified PARP (0.04 nmol). PARP was also incubated alone in the absence of substrate (lane 7). Lower panel: The same filter was stained with AuroDye (GE Healthcare) to reveal the blotted PARylated and non-PARylated proteins. The expected migrations of ISWI, ISWI-N, and ISWI-C are indicated by arrows, whereas PARP is indicated by asterisks.
(D) Larval nuclear extracts derived from larvae expressing TAP-tagged ISWI (ISWI-TAP) and control untagged extracts (ISWI) were affinity purified, as previously described [14]. The ISWI-CBP fusion, consisting of the ISWI protein fused in frame with the calmodulin binding peptide, was eluted from the resin by cleavage with the TEV protease. About 0.05% of the Input extract (I) and supernatant (U), 3% of the eluate (E) were subjected to Western blot analysis with aPAR and aISWI antibodies. Arrows indicate TAP-tagged ISWI (ISWI-TAP), ISWI fused in frame with the calmodulin binding peptide (ISWI-CBP), and endogenous untagged ISWI (ISWI).
(E) Immunoprecipitation with aPAR antibodies, of salivary gland extracts derived from wild type (lanes 1 and 3) and Parg27.1 mutant (lanes 2 and 4) lines. Western blot analysis was performed on the immunoprecipitate with anti-PAR (lanes 1 and 2), anti-ISWI (lanes 3 and 4).
(F) Pull-down of FLAG-ISWI and purified PARP in the presence (lanes 5–8) or absence (lanes 1–4) of activating DNA. Proteins were detected by Western blot using aISWI and aPARP antibodies.
(G) Schematic representation of the domain structure of full length ISWI. The boundaries of the N-terminal (ISWI-N) and C- terminal (ISWI-C) truncated forms of ISWI are depicted.